COMMUNIQUÉS West-GlobeNewswire

Cytek Biosciences Reports Second Quarter 2025 Financial Results
06/08/2025
FREMONT, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Cytek ® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial results for the second [...]
Vaxcyte Reports Second Quarter 2025 Financial Results and Provides Business Update, Highlighting Key Clinical and Regulatory Progress for VAX-31, a Potential Best-in-Class Pneumococcal Conjugate Vaccine (PCV)
06/08/2025
Following Interactions with FDA on VAX-31 Adult Program, Including End-of-Phase 2 Meeting, Company Finalizing Phase 3 Clinical Program to Validate VAX-31 as Potential New Standard-of-Care Adult PCV ; Pivotal, Non- [...]
Inotiv Reports Third Quarter Financial Results for Fiscal 2025 and Provides Business Update
06/08/2025
– Third quarter fiscal 2025 revenue up 23.5% to $130.7 million – Year-to-date fiscal 2025 revenue increased 4.0% to $374.9 million – Conference call scheduled for today at 4:30 pm ET WEST LAFAYETTE, Ind., Aug. 06, 2025 [...]
PROCEPT BioRobotics Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
06/08/2025
SAN JOSE, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions [...]
Revolution Medicines Reports Second Quarter 2025 Financial Results and Update on Corporate Progress
06/08/2025
Strong execution of two ongoing Phase 3 trials of daraxonrasib; for RASolute 302, company is winding down enrollment in U.S. and expects to complete enrollment of the trial this year FDA Breakthrough Therapy [...]
ONWARD Medical annonce la nomination de Lucas Buchanan à son conseil d’administration
06/08/2025
M. Buchanan est l’ancien directeur financier et directeur des opérations de Silk Road Medical, où il a développé avec succès une entreprise de dispositifs médicaux en phase de croissance, aboutissant à son acquisition [...]
Immix Biopharma Announces Other Serious Diseases Strategy
06/08/2025
– Dosing ongoing and planned in a handful of Other Serious Diseases (OSD) – – Company plans to partner-out Other Serious Disease programs – – On track for first Biologics License Application (BLA) approved cell therapy [...]
NADP Foundation Issues Request for Proposals
06/08/2025
DALLAS, Aug. 06, 2025 (GLOBE NEWSWIRE) -- To solicit projects advancing access to oral health care, the National Association of Dental Plans (NADP) Foundation issued its 2025 request for proposal (RFP) on Aug. 1. The [...]

Pages